Demand for lifesaving treatment could outstrip supply

Venous thromboembolism

Demand for a blood component vital in the treatment of cancer and diseases of the immune system is set to outstrip supply unless thousands more donors can be found, HSJ has been told.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here